CN Stock MarketDetailed Quotes

301393 Suzhou Highfine Biotech

Watchlist
  • 40.56
  • -0.20-0.49%
Market Closed Jul 19 15:00 CST
4.38BMarket Cap47.33P/E (TTM)

Suzhou Highfine Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-27.14%91.23M
-13.11%388.79M
-15.80%303.64M
-22.29%210.1M
3.41%125.21M
21.12%447.46M
38.70%360.62M
69.05%270.37M
35.07%121.08M
30.85%369.44M
Operating revenue
-27.14%91.23M
-13.11%388.79M
-15.80%303.64M
-22.29%210.1M
3.41%125.21M
21.12%447.46M
38.70%360.62M
69.05%270.37M
35.07%121.08M
30.85%369.44M
Other operating revenue
----
--0
----
--0
----
--0
----
--0
--0
--7.29K
Total operating cost
-25.86%61.49M
-7.39%278.57M
-8.54%220M
-20.92%144.08M
1.57%82.95M
24.27%300.8M
240.54M
76.08%182.18M
81.66M
5.31%242.05M
Operating cost
-20.91%56.53M
-5.91%238.9M
-11.80%182.97M
-24.33%119.68M
3.11%71.47M
28.32%253.89M
--207.46M
91.24%158.17M
--69.32M
31.78%197.86M
Operating tax surcharges
55.31%600.81K
-25.15%2.53M
-41.26%1.58M
-48.83%1.01M
-64.82%386.84K
7.53%3.39M
--2.69M
29.73%1.97M
--1.1M
27.07%3.15M
Operating expense
26.95%2.18M
25.70%11.95M
43.96%9.46M
1.32%4.97M
-12.60%1.72M
5.55%9.51M
--6.57M
17.34%4.9M
--1.97M
-27.57%9.01M
Administration expense
52.14%5.73M
52.54%24.01M
34.77%16.94M
11.88%9.08M
-17.13%3.77M
1.76%15.74M
--12.57M
0.69%8.12M
--4.55M
-58.73%15.47M
Financial expense
-1,593.07%-13.94M
-583.81%-27.31M
-113.67%-11.07M
40.31%-2.02M
213.99%933.72K
-326.30%-3.99M
---5.18M
-580.07%-3.39M
--297.37K
-63.56%1.76M
-Interest expense (Financial expense)
12.57%16.36K
-81.23%45.27K
-69.33%20.69K
-48.99%23.42K
-36.69%14.53K
165.17%241.19K
--67.47K
-5.75%45.9K
--22.95K
157.78%90.95K
-Interest Income (Financial expense)
-8,561.83%-12.44M
-3,967.73%-27.5M
-1,724.39%-7.37M
-29.93%-380.22K
-105.23%-143.61K
13.88%-676K
---403.72K
42.12%-292.65K
---69.98K
30.11%-784.96K
Research and development
122.67%10.39M
27.91%28.47M
22.48%20.11M
-8.48%11.36M
5.27%4.67M
50.45%22.26M
--16.42M
97.08%12.41M
--4.43M
-34.12%14.8M
Credit Impairment Loss
45.43%-1.25M
-174.12%-560.2K
-960.77%-756.49K
35.23%-976.26K
-159.94%-2.3M
146.90%755.79K
--87.89K
-1,257.94%-1.51M
---883.43K
-1,069.49%-1.61M
Asset Impairment Loss
200.66%634.4K
-475.73%-4.53M
34.96%-969.38K
-32.73%-896.31K
-98.36%-630.23K
-649.01%-787.47K
---1.49M
-968.29%-675.28K
---317.72K
50.39%-105.13K
Other net revenue
2,449.21%4.43M
-9.60%2.34M
2,485.58%6.39M
197.44%1.91M
34.04%-188.73K
46.91%2.58M
-267.75K
-260.89%-1.96M
-286.15K
-17.89%1.76M
Fair value change income
--278K
--224.3K
--2.97M
----
----
----
----
----
----
--1.45K
Invest income
----
281.72%1.51M
679.54%1.51M
198.15%842.48K
-55.68%171.8K
-66.47%395.36K
---260.41K
-272.09%-858.38K
--387.67K
28.97%1.18M
Asset deal income
----
99.90%-129.48
----
----
----
-364.41%-123.41K
---100.74K
----
----
-976.74%-26.57K
Other revenue
86.06%4.77M
143.11%5.7M
143.24%3.64M
171.72%2.94M
386.62%2.57M
0.94%2.34M
--1.5M
61.22%1.08M
--527.33K
82.77%2.32M
Operating profit
-18.79%34.17M
-24.58%112.56M
-24.86%90.03M
-21.21%67.93M
7.51%42.07M
15.56%149.24M
29.20%119.82M
49.49%86.22M
16.99%39.14M
136.37%129.15M
Add:Non operating Income
--101.5K
8.14%29.2K
-12.32%13.34K
-8.23%11.09K
----
425.81%27K
--15.21K
177.38%12.09K
--11.41K
-94.57%5.14K
Less:Non operating expense
--41.25K
-66.11%105.52K
-99.99%45
----
----
204.91%311.33K
--310.41K
114.61%80.44K
--80.44K
-10.46%102.11K
Total profit
-18.65%34.23M
-24.48%112.49M
-24.67%90.04M
-21.14%67.94M
7.70%42.07M
15.43%148.96M
28.93%119.53M
49.45%86.15M
16.78%39.07M
136.28%129.05M
Less:Income tax cost
-23.95%4.4M
-31.01%13.51M
-31.93%11.14M
-20.44%9.21M
-3.05%5.79M
10.98%19.59M
--16.37M
56.16%11.57M
--5.97M
24.14%17.65M
Net profit
-17.80%29.83M
-23.50%98.97M
-23.52%78.9M
-21.24%58.74M
9.64%36.29M
16.13%129.37M
28.73%103.16M
48.47%74.58M
15.94%33.1M
175.73%111.4M
Net profit from continuing operation
-17.80%29.83M
-23.50%98.97M
-23.52%78.9M
-21.24%58.74M
9.64%36.29M
16.13%129.37M
--103.16M
48.47%74.58M
--33.1M
175.73%111.4M
Net profit of parent company owners
-17.80%29.83M
-23.50%98.97M
-23.52%78.9M
-21.24%58.74M
9.64%36.29M
16.13%129.37M
28.73%103.16M
48.47%74.58M
15.94%33.1M
175.73%111.4M
Earning per share
Basic earning per share
-37.78%0.28
-33.13%1.07
-28.35%0.91
-20.65%0.73
9.76%0.45
15.94%1.6
--1.27
48.39%0.92
--0.41
176.00%1.38
Diluted earning per share
-37.78%0.28
-33.13%1.07
-28.35%0.91
-20.65%0.73
9.76%0.45
15.94%1.6
--1.27
48.39%0.92
--0.41
176.00%1.38
Other composite income
Total composite income
-17.80%29.83M
-23.50%98.97M
-23.52%78.9M
-21.24%58.74M
9.64%36.29M
16.13%129.37M
103.16M
48.47%74.58M
33.1M
175.73%111.4M
Total composite income of parent company owners
-17.80%29.83M
-23.50%98.97M
-23.52%78.9M
-21.24%58.74M
9.64%36.29M
16.13%129.37M
--103.16M
48.47%74.58M
--33.1M
175.73%111.4M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
--
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
--
--
--
Zhongtianyun Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -27.14%91.23M-13.11%388.79M-15.80%303.64M-22.29%210.1M3.41%125.21M21.12%447.46M38.70%360.62M69.05%270.37M35.07%121.08M30.85%369.44M
Operating revenue -27.14%91.23M-13.11%388.79M-15.80%303.64M-22.29%210.1M3.41%125.21M21.12%447.46M38.70%360.62M69.05%270.37M35.07%121.08M30.85%369.44M
Other operating revenue ------0------0------0------0--0--7.29K
Total operating cost -25.86%61.49M-7.39%278.57M-8.54%220M-20.92%144.08M1.57%82.95M24.27%300.8M240.54M76.08%182.18M81.66M5.31%242.05M
Operating cost -20.91%56.53M-5.91%238.9M-11.80%182.97M-24.33%119.68M3.11%71.47M28.32%253.89M--207.46M91.24%158.17M--69.32M31.78%197.86M
Operating tax surcharges 55.31%600.81K-25.15%2.53M-41.26%1.58M-48.83%1.01M-64.82%386.84K7.53%3.39M--2.69M29.73%1.97M--1.1M27.07%3.15M
Operating expense 26.95%2.18M25.70%11.95M43.96%9.46M1.32%4.97M-12.60%1.72M5.55%9.51M--6.57M17.34%4.9M--1.97M-27.57%9.01M
Administration expense 52.14%5.73M52.54%24.01M34.77%16.94M11.88%9.08M-17.13%3.77M1.76%15.74M--12.57M0.69%8.12M--4.55M-58.73%15.47M
Financial expense -1,593.07%-13.94M-583.81%-27.31M-113.67%-11.07M40.31%-2.02M213.99%933.72K-326.30%-3.99M---5.18M-580.07%-3.39M--297.37K-63.56%1.76M
-Interest expense (Financial expense) 12.57%16.36K-81.23%45.27K-69.33%20.69K-48.99%23.42K-36.69%14.53K165.17%241.19K--67.47K-5.75%45.9K--22.95K157.78%90.95K
-Interest Income (Financial expense) -8,561.83%-12.44M-3,967.73%-27.5M-1,724.39%-7.37M-29.93%-380.22K-105.23%-143.61K13.88%-676K---403.72K42.12%-292.65K---69.98K30.11%-784.96K
Research and development 122.67%10.39M27.91%28.47M22.48%20.11M-8.48%11.36M5.27%4.67M50.45%22.26M--16.42M97.08%12.41M--4.43M-34.12%14.8M
Credit Impairment Loss 45.43%-1.25M-174.12%-560.2K-960.77%-756.49K35.23%-976.26K-159.94%-2.3M146.90%755.79K--87.89K-1,257.94%-1.51M---883.43K-1,069.49%-1.61M
Asset Impairment Loss 200.66%634.4K-475.73%-4.53M34.96%-969.38K-32.73%-896.31K-98.36%-630.23K-649.01%-787.47K---1.49M-968.29%-675.28K---317.72K50.39%-105.13K
Other net revenue 2,449.21%4.43M-9.60%2.34M2,485.58%6.39M197.44%1.91M34.04%-188.73K46.91%2.58M-267.75K-260.89%-1.96M-286.15K-17.89%1.76M
Fair value change income --278K--224.3K--2.97M--------------------------1.45K
Invest income ----281.72%1.51M679.54%1.51M198.15%842.48K-55.68%171.8K-66.47%395.36K---260.41K-272.09%-858.38K--387.67K28.97%1.18M
Asset deal income ----99.90%-129.48-------------364.41%-123.41K---100.74K---------976.74%-26.57K
Other revenue 86.06%4.77M143.11%5.7M143.24%3.64M171.72%2.94M386.62%2.57M0.94%2.34M--1.5M61.22%1.08M--527.33K82.77%2.32M
Operating profit -18.79%34.17M-24.58%112.56M-24.86%90.03M-21.21%67.93M7.51%42.07M15.56%149.24M29.20%119.82M49.49%86.22M16.99%39.14M136.37%129.15M
Add:Non operating Income --101.5K8.14%29.2K-12.32%13.34K-8.23%11.09K----425.81%27K--15.21K177.38%12.09K--11.41K-94.57%5.14K
Less:Non operating expense --41.25K-66.11%105.52K-99.99%45--------204.91%311.33K--310.41K114.61%80.44K--80.44K-10.46%102.11K
Total profit -18.65%34.23M-24.48%112.49M-24.67%90.04M-21.14%67.94M7.70%42.07M15.43%148.96M28.93%119.53M49.45%86.15M16.78%39.07M136.28%129.05M
Less:Income tax cost -23.95%4.4M-31.01%13.51M-31.93%11.14M-20.44%9.21M-3.05%5.79M10.98%19.59M--16.37M56.16%11.57M--5.97M24.14%17.65M
Net profit -17.80%29.83M-23.50%98.97M-23.52%78.9M-21.24%58.74M9.64%36.29M16.13%129.37M28.73%103.16M48.47%74.58M15.94%33.1M175.73%111.4M
Net profit from continuing operation -17.80%29.83M-23.50%98.97M-23.52%78.9M-21.24%58.74M9.64%36.29M16.13%129.37M--103.16M48.47%74.58M--33.1M175.73%111.4M
Net profit of parent company owners -17.80%29.83M-23.50%98.97M-23.52%78.9M-21.24%58.74M9.64%36.29M16.13%129.37M28.73%103.16M48.47%74.58M15.94%33.1M175.73%111.4M
Earning per share
Basic earning per share -37.78%0.28-33.13%1.07-28.35%0.91-20.65%0.739.76%0.4515.94%1.6--1.2748.39%0.92--0.41176.00%1.38
Diluted earning per share -37.78%0.28-33.13%1.07-28.35%0.91-20.65%0.739.76%0.4515.94%1.6--1.2748.39%0.92--0.41176.00%1.38
Other composite income
Total composite income -17.80%29.83M-23.50%98.97M-23.52%78.9M-21.24%58.74M9.64%36.29M16.13%129.37M103.16M48.47%74.58M33.1M175.73%111.4M
Total composite income of parent company owners -17.80%29.83M-23.50%98.97M-23.52%78.9M-21.24%58.74M9.64%36.29M16.13%129.37M--103.16M48.47%74.58M--33.1M175.73%111.4M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Zhongtianyun Certified Public Accountants (Special General Partnership)------Zhongtianyun Certified Public Accountants (Special General Partnership)------Zhongtianyun Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg